Plasma Oxalate and Kidney Function Are Correlated in Patients With Primary Hyperoxaluria With Maintained Kidney Function – Data From Three Placebo-Controlled Studies Published
UF startup OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces the publication of an article in Pediatric Nephrology, on the significant correlation between plasma oxalate and kidney function in three controlled clinical trials with PH patients.
Algernon Pharmaceuticals Lead Drug Ifenprodil Named As Potential COVID-19 Treatment in European Scientific Journal
Algernon Pharmaceuticals Inc., formerly known as Breathtec, a UF startup, said that its lead drug candidate Ifenprodil was highlighted in a European... Read More
UF Startup Shadow Health Is Going Big and Staying Home
In early December, local UF startup Shadow Health, which develops virtual simulations for nursing and healthcare education, became part of Elsevier, a global leader in information and analytics, that is part of RELX, an even larger global provider of information-based analytics. The acquisition will hasten Shadow Health’s ability to reach its biggest goals.
